Clinical Trials Directory

Trials / Terminated

TerminatedNCT02902835

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3

BUPrenorphine Facilitated Access and Supportive Treatment--AIM 3

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to test whether peer mentors (i.e., individuals with past opioid addiction and prior incarceration) can facilitate entrance into buprenorphine (Suboxone) treatment for individuals with opioid use disorder who were recently released from jail or prison. In order to test whether it is helpful to have peer mentors paired with recently released individuals, the investigators will conduct an 18 month study, recruiting 72 formerly incarcerated individuals and assigning them by chance selection (like flipping a coin) to either a group that will receive peer mentorship or a group that will receive a referral to a community clinic.

Detailed description

BUPrenorphine Facilitated Access and Supportive Treatment (BUP-FAST) is a peer mentorship intervention in which trained peer mentors will link formerly incarcerated individuals with opioid use disorder to addiction treatment (i.e. buprenorphine maintenance treatment) following release from incarceration. The current study is a pilot randomized control trial evaluating the effectiveness and feasibility of the peer mentorship intervention. The investigators are conducting this study due to the high rates of relapse to opioid use following release from prison (up to 75% within 3 months) and difficulty that some formerly incarcerated individuals report in accessing effective treatments for opioid use disorder. The investigators hypothesize that having peer mentors - who themselves have experienced incarceration and have had success with buprenorphine treatment for opioid use disorder - assisting formerly incarcerated individuals in seeking treatment will result in higher rates of linkage to care in comparison to referral to a community health center for buprenorphine treatment. In this 18-month randomized control trial of the BUP-FAST intervention, the investigators will recruit 72 formerly incarcerated individuals with opioid use disorder; half will then be randomized to receive the BUP-FAST intervention (peer mentorship); and the other half (control) will receive referral to a community health center for assessment for buprenorphine treatment. Medication will not be provided as part of this study. Participants will only receive buprenorphine treatment if they meet appropriate medical criteria after assessment at the community health center.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBUP_FASTPeer mentorship including: buprenorphine education, identifying buprenorphine providers, accompaniment at appointments, and psychosocial support (via outreach phone calls)
BEHAVIORALReferral to treatmentParticipants will receive a pamphlet describing the buprenorphine treatment program at a Montefiore community health center.

Timeline

Start date
2016-09-01
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2016-09-16
Last updated
2018-09-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02902835. Inclusion in this directory is not an endorsement.

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3 (NCT02902835) · Clinical Trials Directory